18F-FDG PET-CT in soft tissue sarcomas: staging, restaging, and prognostic value?

Area of Science:

• Oncology
• Radiology
• Medical Imaging

Background:

• Soft tissue sarcomas are rare malignancies requiring accurate staging and monitoring.
• Distinguishing recurrent tumors from post-treatment changes like scar tissue can be challenging.

Purpose of the Study:

• To review the current applications of PET/CT in soft tissue sarcomas.
• To evaluate its role in staging, restaging, and prognostic assessment.
• To discuss current and future indications, including novel therapies.

Main Methods:

• Review of existing literature on PET/CT in soft tissue sarcomas.
• Discussion of specific imaging findings and their interpretation.
• Consideration of PET/MRI as an emerging technique.

Main Results:

• Fluorine-18-fluorodeoxyglucose PET (FDG-PET) is effective in differentiating recurrent disease from scar tissue.
• PET/CT offers valuable insights for staging and prognostic evaluation.
• Emerging applications are expanding with new molecular drugs.

Conclusions:

• PET/CT is an important tool in the management of soft tissue sarcomas.
• Its utility extends to follow-up, aiding in early detection of recurrence.
• Further research into PET/CT and PET/MRI is warranted for optimizing patient care.